Access to anti-retroviral drugs, female in Jordan
Jordan: Access to anti-retroviral drugs, female was 67.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Jordan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Jordan recorded 67.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 8.1% on the previous year and up 86.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Jordan peaked at 67.0% in 2024 and was at its lowest, 7.0%, in 2003.
That places Jordan 88th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Jordan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 8.0% | — |
| 2001 | 8.0% | +0.0% |
| 2002 | 8.0% | +0.0% |
| 2003 | 7.0% | -12.5% |
| 2004 | 11.0% | +57.1% |
| 2005 | 16.0% | +45.5% |
| 2006 | 20.0% | +25.0% |
| 2007 | 19.0% | -5.0% |
| 2008 | 20.0% | +5.3% |
| 2009 | 23.0% | +15.0% |
| 2010 | 28.0% | +21.7% |
| 2011 | 32.0% | +14.3% |
| 2012 | 39.0% | +21.9% |
| 2013 | 37.0% | -5.1% |
| 2014 | 36.0% | -2.7% |
| 2015 | 36.0% | +0.0% |
| 2016 | 40.0% | +11.1% |
| 2017 | 45.0% | +12.5% |
| 2018 | 52.0% | +15.6% |
| 2019 | 56.0% | +7.7% |
| 2020 | 58.0% | +3.6% |
| 2021 | 52.0% | -10.3% |
| 2022 | 59.0% | +13.5% |
| 2023 | 62.0% | +5.1% |
| 2024 | 67.0% | +8.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.0% | 7.0% | 23.0% | 10 |
| 2010s | 40.1% | 28.0% | 56.0% | 10 |
| 2020s | 59.6% | 52.0% | 67.0% | 5 |
Countries ranked near Jordan
- 86 Dominican Republic 68.0% compare
- 86 Mauritania 68.0% compare
- 88 Barbados 67.0% compare
- 88 Iraq 67.0% compare
- 91 Algeria 65.0% compare
- 91 Costa Rica 65.0% compare
- 91 Malaysia 65.0% compare
- 91 Montenegro 65.0% compare
More gender data for Jordan
- Child population (UN estimates and projections) 3,402 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.1309 % change on previous year (2030)
- Population 9,047 (2030)
- Working-age population (UN estimates and projections) 9,047 (2030)
- Population (UN estimates and projections), annual growth rate 2.35 % change on previous year (2030)
- Age population, age 00, female, interpolated 110,553 (2025)
- Age population, age 00, male, interpolated 115,505 (2025)
- Age population, age 01, female, interpolated 110,528 (2025)
- Age population, age 01, male, interpolated 115,418 (2025)
- Age population, age 02, female, interpolated 110,346 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Jordan?
- Access to anti-retroviral drugs, female in Jordan was 67.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Jordan?
- The highest recorded value was 67.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Jordan?
- The lowest recorded value was 7.0% in 2003.
- How does Jordan rank for access to anti-retroviral drugs, female?
- Jordan ranks 88th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Jordan?
- Over the last ten years it is up 86.1%. The long-run trend across the full record is volatile.
- Where does this Jordan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.